20250206743. Tyk2 Inh (TAKEDA PHARMACEUTICAL LIMITED)
TYK2 INHIBITOR SYNTHESIS AND INTERMEDIATES THEREOF
Abstract: described herein are methods of synthesis of a tyrosine-protein kinase 2 (tyk2) inhibitor and to intermediate compounds of the synthesis and methods of making the intermediates. also provided are pharmaceutically acceptable compositions including compounds prepared by the synthetic method and methods of treating disorders using the same.
Inventor(s): Craig E. MASSE, Avinash S. PHADKE, Jon P. LAWSON, Stuart LEVY, Xiaowei YANG, Guisheng WU, Shufeng FAN
CPC Classification: C07D487/04 (Ortho-condensed systems)
Search for rejections for patent application number 20250206743